| Item Type | Name |
|
Concept
|
Neoadjuvant Therapy
|
|
Academic Article
|
Combined modality therapy in esophageal cancer: the Memorial experience.
|
|
Academic Article
|
Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation.
|
|
Academic Article
|
Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
|
|
Academic Article
|
Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection.
|
|
Academic Article
|
Is preoperative chemoradiotherapy still the treatment of choice for rectal cancer?
|
|
Academic Article
|
Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence.
|
|
Academic Article
|
Tumor regression grading in rectal cancer: is it time to move forward?
|
|
Academic Article
|
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography.
|
|
Academic Article
|
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?
|
|
Academic Article
|
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
|
|
Academic Article
|
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.
|
|
Academic Article
|
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005.
|
|
Academic Article
|
Multidisciplinary management of resectable rectal cancer. New developments and controversies.
|
|
Academic Article
|
Progress in the treatment of locally advanced clinically resectable rectal cancer.
|
|
Academic Article
|
Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study.
|
|
Academic Article
|
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
|
|
Academic Article
|
Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria.
|
|
Academic Article
|
Abdominoperineal resection for rectal cancer at a specialty center.
|
|
Academic Article
|
Combined-modality therapy of rectal cancer with irinotecan-based regimens.
|
|
Academic Article
|
Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer.
|
|
Academic Article
|
Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection?
|
|
Academic Article
|
American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
|
|
Academic Article
|
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.
|
|
Academic Article
|
Adjuvant management of rectal cancer: the more we learn, the less we know.
|
|
Academic Article
|
Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
|
|
Academic Article
|
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007.
|
|
Academic Article
|
Extended perineal resection of distal rectal cancers: surgical advance, increased utilization of neoadjuvant therapies, proper patient selection or all of the above?
|
|
Academic Article
|
Counterpoint: long-course chemoradiation is preferable in the neoadjuvant treatment of rectal cancer.
|
|
Academic Article
|
Have the changes in treatment of rectal cancer made a significant difference to our patients?
|
|
Academic Article
|
Locally unresectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria.
|
|
Academic Article
|
Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy.
|
|
Academic Article
|
Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer.
|
|
Academic Article
|
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
|
|
Academic Article
|
Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy.
|
|
Academic Article
|
The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation.
|
|
Academic Article
|
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality.
|
|
Academic Article
|
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.
|
|
Academic Article
|
Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.
|
|
Academic Article
|
Neoadjuvant Treatment Strategies: Advanced Radiation Alternatives.
|
|
Academic Article
|
Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.
|
|
Academic Article
|
Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.
|
|
Academic Article
|
Emerging trends in the treatment of rectal cancer.
|
|
Academic Article
|
Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer.
|
|
Academic Article
|
Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma.
|
|
Academic Article
|
Impact of tumor regression grade on recurrence after preoperative chemoradiation and gastrectomy for gastric cancer.
|
|
Academic Article
|
Tumor Regression Grade in Gastric Cancer After Preoperative Therapy.
|
|
Academic Article
|
Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal Cancer: A Post Hoc Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
|
|
Academic Article
|
Chemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience.
|
|
Academic Article
|
Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer: a Western perspective.
|
|
Academic Article
|
Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival.
|
|
Academic Article
|
Determinants of Survival for Patients with Neoadjuvant-Treated Node-Negative Gastric Cancer.
|
|
Academic Article
|
Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis.
|
|
Academic Article
|
Impact of body-mass index on treatment and outcome in locally advanced rectal cancer: A secondary, post-hoc analysis of the CAO/ARO/AIO-04 randomized phase III trial.
|
|
Academic Article
|
Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer.
|
|
Academic Article
|
Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local Recurrence.
|
|
Academic Article
|
Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection.
|